We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+3.18%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$132M
AUM Growth
-$232K
Cap. Flow
-$3.87M
Cap. Flow %
-2.93%
Top 10 Hldgs %
30.95%
Holding
149
New
10
Increased
20
Reduced
79
Closed
14

Top Buys

Rank Stock Value
1
BAB icon
Invesco Taxable Municipal Bond ETF
BAB
+$1.73M
2
AGN
Allergan plc
AGN
+$1.18M
3
CVX icon
Chevron
CVX
+$585K
4
BAY
BAYER AG SPONS ADR
BAY
+$484K
5
ESRX
Express Scripts Holding Company
ESRX
+$396K

Top Sells

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$1.19M
2
ARG
Airgas Inc
ARG
+$1.11M
3
RJI
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
+$984K
4
USCI icon
US Commodity Index
USCI
+$762K
5
IYM icon
iShares US Basic Materials ETF
IYM
+$500K

Sector Composition

Rank Sector Weight
1 Healthcare 25.99%
2 Financials 11.94%
3 Technology 11.84%
4 Industrials 11.29%
5 Consumer Staples 7.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
26
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.52M 1.15%
7
– –
KO icon
27
Coca-Cola
KO
$376B
$1.51M 1.15%
33,403
-3,485
-9% -$157K
DGX icon
28
Quest Diagnostics
DGX
$25.9B
$1.51M 1.15%
18,548
-170
-0.9% -$12.9K
MTB icon
29
M&T Bank
MTB
$35.8B
$1.5M 1.13%
12,651
+101
+0.8% +$11.7K
ABT icon
30
Abbott
ABT
$183B
$1.49M 1.13%
37,935
+728
+2% +$29K
CHRW icon
31
C.H. Robinson
CHRW
$17.5B
$1.49M 1.13%
20,025
-225
-1% -$16.4K
ETR icon
32
Entergy
ETR
$50.6B
$1.38M 1.05%
33,950
-160
-0.5% -$6.14K
BDX icon
33
Becton Dickinson
BDX
$45.5B
$1.23M 0.93%
7,421
-559
-7% -$89.4K
AGN
34
DELISTED
Allergan plc
AGN
$1.19M 0.9%
+5,132
New +$1.18M
AMGN icon
35
Amgen
AMGN
$208B
$1.15M 0.87%
7,579
– –
ESRX
36
DELISTED
Express Scripts Holding Company
ESRX
$1.15M 0.87%
15,165
+5,390
+55% +$396K
RTX icon
37
RTX Corp
RTX
$290B
$1.12M 0.85%
17,374
+1,708
+11% +$109K
NVS icon
38
Novartis
NVS
$297B
$1.08M 0.82%
14,581
+224
+2% +$15.5K
NSC icon
39
Norfolk Southern
NSC
$75.3B
$1.07M 0.82%
12,625
-100
-0.8% -$8.5K
VZ icon
40
Verizon
VZ
$194B
$1.07M 0.81%
19,099
-413
-2% -$21.4K
VWO icon
41
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$1.06M 0.81%
30,213
-12,320
-29% -$421K
STT icon
42
State Street
STT
$50.7B
$1.06M 0.8%
19,642
-4,214
-18% -$252K
TECH icon
43
Bio-Techne
TECH
$11.2B
$1M 0.76%
35,648
-9,996
-22% -$257K
WMT icon
44
Walmart Inc
WMT
$885B
$983K 0.75%
40,404
-1,059
-3% -$24.5K
VIG icon
45
Vanguard Dividend Appreciation ETF
VIG
$111B
$967K 0.73%
11,616
+550
+5% +$44.9K
TEVA icon
46
Teva Pharmaceuticals
TEVA
$40.8B
$902K 0.68%
17,950
+20
+0.1% +$1.06K
COP icon
47
ConocoPhillips
COP
$145B
$864K 0.66%
19,826
-3,686
-16% -$163K
CNC icon
48
Centene
CNC
$30.6B
$838K 0.64%
23,472
– –
CME icon
49
CME Group
CME
$96.5B
$836K 0.63%
8,584
-921
-10% -$87K
MDT icon
50
Medtronic
MDT
$109B
$811K 0.62%
9,343
-387
-4% -$31.3K
1
2
3 4 5

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Roberts, Glore & Co held 149 positions worth $132M, down 0.18% from $132M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Roberts, Glore & Co's Q2 2016 filing shows 10 new, 20 increased, 79 reduced and 14 closed positions. Its largest new stake was Allergan plc: 5,132 shares worth $1.19M. The largest sale was Sprott Physical Gold and Silver Trust, an estimated $1.19M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 23% a quarter earlier, followed by Financials and Technology.

  • Roberts, Glore & Co's largest Q2 2016 buy was Allergan plc: 5,132 shares worth $1.19M.
  • Roberts, Glore & Co added most to Invesco Taxable Municipal Bond ETF in Q2 2016, an estimated $1.73M increase.
  • Roberts, Glore & Co's biggest Q2 2016 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $421K.
  • Roberts, Glore & Co fully exited Sprott Physical Gold and Silver Trust in Q2 2016, selling an estimated $1.19M.
  • Roberts, Glore & Co's ten largest holdings make up 31% of its $132M portfolio in Q2 2016.
  • Roberts, Glore & Co opened 10 new positions and closed 14 in Q2 2016.
  • Roberts, Glore & Co's portfolio value fell 0.18% quarter-over-quarter to $132M.

Based on Roberts, Glore & Co's 13F filing for Q2 2016, filed 28 Jul 2016.